Roche Holding reported that first-half net profit fell 7% on currency losses, although solid demand for its cancer therapies allowed the Swiss drug giant to confirm its full-year business outlook.
from WSJ.com: US Business http://ift.tt/1JzRziz
via IFTTT
No comments:
Post a Comment